Hydroxyproline metabolism in a mouse model of Primary Hyperoxaluria Type 3

Area of Science:

• Metabolic disorders
• Genetics
• Biochemistry

Background:

• Primary Hyperoxaluria Type 3 (PH3) is an autosomal recessive disease.
• It stems from mutations in the 4-hydroxy-2-oxoglutarate aldolase (HOGA1) gene, crucial for hydroxyproline catabolism.
• Affected individuals exhibit elevated urinary oxalate, 4-hydroxy-L-glutamate (4-OH-Glu), 4-hydroxy-2-oxoglutarate (HOG), and 2,4-dihydroxyglutarate (DHG).

Purpose of the Study:

• To investigate the biochemical pathways of PH3.
• To develop and characterize a mouse model for PH3 research.
• To understand the relationship between HOGA1 deficiency, metabolite excretion, and disease development.

Main Methods:

• Developed a mouse model with null mutations in the Hoga1 gene.
• Characterized the phenotype of the Hoga1 knockout (KO) mice.
• Administered hydroxyproline-rich diets to challenge the mouse model.

Main Results:

• The Hoga1 KO mouse model exhibits characteristics similar to human PH3, especially when fed a hydroxyproline-rich diet.
• Increased urinary oxalate excretion was not observed in KO mice.
• This finding aligns with the observation that not all individuals with HOGA1 deficiency develop PH.

Conclusions:

• The Hoga1 KO mouse is a valuable model for studying PH3.
• Further research is needed to clarify the metabolic pathways of DHG formation and HOG to oxalate conversion.
• Understanding these pathways may reveal therapeutic targets for PH3.